Jose Di Conza
Overview
Explore the profile of Jose Di Conza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez-Espinosa F, Di Pilato V, Magarinos F, Di Conza J, Rossolini G, Gutkind G, et al.
J Glob Antimicrob Resist
. 2024 Apr;
37:176-178.
PMID: 38583573
Objectives: To describe at genomic level nine carbapenemase-producing Klebsiella pneumoniae ST307 (Kp-ST307) clinical isolates recovered in Buenos Aires during 2017 to 2021, investigating their resistome, virulome, and phylogeny. Methods: Antimicrobial...
2.
Ruggiero M, Brunetti F, Dabos L, Girlich D, Briceno Munoz J, Di Conza J, et al.
Int J Antimicrob Agents
. 2023 May;
62(1):106850.
PMID: 37178777
The production of PER-like extended-spectrum β-lactamases has recently been associated with reduced susceptibility to the last resort drugs aztreonam/avibactam and cefiderocol. PER-2 has been mainly confined to Argentina and neighboring...
3.
Di Gregorio S, Haim M, Famiglietti A, Di Conza J, Mollerach M
Antibiotics (Basel)
. 2023 Feb;
12(2).
PMID: 36830286
Infections due to vancomycin-intermediate (VISA) and heterogeneous VISA (hVISA) represent a serious concern due to their association with vancomycin treatment failure. However, the underlying molecular mechanism responsible for the hVISA/VISA...
4.
Di Conza J, Badaracco M, Calza Y, Fontana H, Lincopan N, Pena L, et al.
Microb Drug Resist
. 2022 Aug;
28(10):957-961.
PMID: 35984997
An unusual biotype of KPC-2-producing (KPC-Kpn) isolates was detected in Corrientes, Argentina, which, to their isolation date, had been free of KPC-Kpn outbreaks. Our aim was to describe the clinical...
5.
Vasquez-Ponce F, Dantas K, Becerra J, Melocco G, Esposito F, Cardoso B, et al.
Microbiol Spectr
. 2022 Aug;
10(5):e0115922.
PMID: 35980188
Reports of Gram-negative bacteria harboring multiple carbapenemase genes have increased in South America, leading to an urgent need for appropriate microbiological diagnosis. We evaluated phenotypic methods for detecting Klebsiella pneumoniae...
6.
Alcaraz E, Ghiglione B, Pineda M, Mangano A, Di Conza J, Passerini de Rossi B
Res Microbiol
. 2021 Dec;
173(3):103917.
PMID: 34890712
Stenotrophomonas maltophilia intrinsic resistance to β-lactams is mediated by two chromosomal β-lactamases, L1 and L2, whose induction depends on AmpR. Its quorum sensing (QS) signal, the diffusible signal factor (DSF),...
7.
Gonzales-Escalante E, Ruggiero M, Cerdeira L, Esposito F, Fontana H, Lincopan N, et al.
Microb Drug Resist
. 2021 Oct;
28(2):171-179.
PMID: 34698586
The increasing prevalence and dissemination of carbapenemase-producing represent a serious concern for public health. We studied the genetic features of a multidrug-resistant isolate of high-risk clone ST147 coharboring -1 and...
8.
Ghiglione B, Haim M, Penzotti P, Brunetti F, D Amico Gonzalez G, Di Conza J, et al.
Front Cell Infect Microbiol
. 2021 Sep;
11:722536.
PMID: 34504809
Untreated wastewater is a reservoir for multidrug-resistant bacteria, but its role in the spread of antibiotic resistance in the human population remains poorly investigated. In this study, we isolated a...
9.
Costa A, Figueroa-Espinosa R, Gaudenzi F, Lincopan N, Fuga B, Ghiglione B, et al.
Front Cell Infect Microbiol
. 2021 May;
11:654852.
PMID: 33996632
New Delhi metallo-β-lactamase (NDM)-producing isolates are usually resistant to most β-lactams and other antibiotics as a result of the coexistence of several resistance markers, and they cause a variety of...
10.
Rumi M, Nuske E, Mas J, Arguello A, Gutkind G, Di Conza J
Zoonoses Public Health
. 2021 May;
68(5):516-526.
PMID: 33966360
The widespread use of antimicrobial therapy in companion animals could lead to increased levels of resistance. Monitoring these levels is critical to understand not only the zoonotic threat of resistant...